CME Group stock slips to $239.46 amid persistent bearish signals and mounting sell pressure

CME Group stock slips to $239.46 amid persistent bearish signals and mounting sell pressure
CME Group drops 2.31% today

CME Group announced the planned launch of Single Stock futures on July 27. The company said the launch date is pending completion of all regulatory review and processes.

CME Group is featuring input from its clients as part of the countdown to the new product rollout. Details on regulatory progress or further product specifications were not disclosed.

Highlights

  • CME Group shares display short-term stabilization above immediate support but remain pressured well below medium- and long-term averages.
  • Momentum indicators overwhelmingly signal downside, with MACD, ADX, and weekly technicals confirming continued bearish trend dominance.
  • Expected trading remains constrained between $235 and $245, with a breakout below $235 risking renewed tests of annual lows.

Short-term stabilization as long-term bearish signals persist below key levels

CME Group shares are trading at $239.46, just above the MA-20 ($237.05) but significantly below the MA-50 ($259.33) and MA-200 ($278.99), which points to short-term stabilization amid pronounced medium- and long-term bearish trends. The Ichimoku Kijun on D1 stands at $243.95, marking immediate resistance just above the current price; near-term support is seen at the MA-20 ($237.05), with key support at the MA-200 (W1) around $243.23, while near-term resistance aligns with the Kijun ($243.95), and key resistance lies at the MA-50 ($259.33).

Bearish momentum reinforced by weekly declines and mixed oscillator signals

Momentum remains decisively negative, as both MACD and ADX on D1 issue sell signals, confirming prevailing bearish pressure. RSI hovers in neutral territory at 48.89, but Stoch RSI shows an overbought reading and CCI points modestly upward, revealing some divergence in oscillator signals. BBP is overbought on D1 but shifts to oversold on shorter timeframes, suggesting sellers still dominate intraday momentum despite some mixed signals. CME has fallen $5.59 (2.28%) from the previous week's close of $245.05 and is now at the very bottom of its weekly range near $241.22, while weekly volatility stands at 2.83%. The week has been marked by a steady decline from the high, reinforced by today’s additional drop of 2.31%.

Further downside favored as sustained rebound odds remain weak

For the upcoming week, the expected price range for CME sits between $235 and $245, keeping well within 5% of the current price and reflecting a stabilization band near the lower third of the annual range, which spans from $218.31 to $329.16. Based on the strong sell signals from all key W1 indicators (RSI, ADX, MACD, and MA-50), there is a very low probability (less than 20%) of a sustained move higher, making further downside the more likely scenario. Baseline expectation is for price to oscillate sideways in the $235–$245 channel. A bullish breakout scenario could see the price push above $245 and target resistance near the MA-50, while a bearish scenario involves a breakdown below $235 toward the next major support zones, bringing the yearly low back into focus.

Earlier, analysts noted that CME Group was regaining technical strength, with traders watching for confirmation of sustained bullish momentum after a period of weakness. As market dynamics evolve, investors should closely monitor for clear shifts in directional momentum to identify timely entry and exit opportunities.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.